Health Condition 1: null- Thrombocytopenia induced by Chemotherapy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female aged between 18-55 years. 2. Subjects must sign with date an informed consent prior to any evaluation and participation in the trial. 3. Patients who were confirmed solid tumour and received at least one cycle of chemotherapy prior to screening visit. 4. Patients with a platelet counts between > 20000 and
Exclusion criteria
Exclusion criteria: 1. Planning to receive any type of surgery. 2. Pregnant or lactating women. 3. Patients with platelet count less than 20000/ml. 4. Patients with thrombocytopenia presenting with active bleeding. 5. Patients who have received blood or blood product transfusion during the current illness or during past one week. 6. Patients with thrombocytopenia purpura (ITP) leukemia, hemophilia or bleeding diathesis. 7. Participation in another trial with another investigational product.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase in the platelet counts from baseline levels to the end of therapy.Timepoint: Day 0 to Day 15 | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of Study DrugTimepoint: Day 15 | — |
Countries
India
Contacts
Socrates School Of Health